DigiBiomics Information

DigiBiomics is an AI-driven healthcare technology company transforming medical data into clinical intelligence. Our flagship product, lungSense, is an AI-powered platform for precise lung disease detection and classification. LungSense brings specialist-level diagnostic intelligence directly to point-of-care settings, long-term care facilities, skilled nursing facilities, home care, telehealth, and remote clinics. The impact is significant. LungSense improves patient outcomes through early detection and triage recommendations. It enables healthcare organizations to scale quality care across distributed networks, regardless of location. Beyond our flagship product, DigiBiomics supports clinical research and development through customized clinical data services, advanced AI support, and intelligent automation. We work with healthcare organizations and researchers to unlock insights from their medical data, accelerate innovation, and streamline clinical workflows through purpose-built AI solutions.

Website	https://www.digibiomics.com
Employees	15 (9 on RocketReach)
Founded	2021
Address	2000 Argentia Rd, Suit 400, Plaza 3, Mississauga, Ontario L5N 1V9, CA
Phone	+1 647-882-9464
Industry	IT System Data Services
Keywords	Medical Data Analysis, Digital Health, Ai Healthcare, Precision Medicine, Data Driven Healthcare, Artificial Intelligence Medicine, Evidence Based Medicine, Machine Learning Diagnostics, Predictive Diagnostics, Big Data Healthcare, Clinical Decision Support, Computational Biology, Health Analytics, Medical Informatics, Drug Discovery, Bioinformatics, Advanced Analytics, Genomics, Proteomics
Competitors	Roche, Thermo Fisher Scientific, Boehringer Ingelheim, Illumina, Bio-Rad Laboratories, QIAGEN, Ajinomoto Co., Inc., Oxford Nanopore Technologies, Fulgent Genetics, Zymo Research Corp +40 more (view full list)